HRTX
insider transactionsHERON THERAPEUTICS, INC. /DE/ — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Ira Duarte KEY
EVP, Chief Financial Officer
$0
12.5K sh
Own New
-
Other·F
Ira Duarte KEY
EVP, Chief Financial Officer
$1.4K
3.6K sh · $0.38
Own -1%
-
Exercise·M
Ira Duarte KEY
EVP, Chief Financial Officer
—
12.5K sh
Own +5%
-
Exercise·M
EVP, Chief Development Officer
$0
12.5K sh
Own New
-
Exercise·M
EVP, Chief Development Officer
—
12.5K sh
Own +6%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Ira Duarte KEY | Exercise M | 12.5K | $0 |
| Jun 16, 2026 | Ira Duarte KEY | Other F | 3.6K | $1.4K |
| Jun 16, 2026 | Ira Duarte KEY | Exercise M | 12.5K | — |
| Jun 6, 2026 | William P Forbes | Exercise M | 12.5K | $0 |
| Jun 6, 2026 | William P Forbes | Exercise M | 12.5K | — |
About HRTX insider trading
This page tracks insider transactions for HERON THERAPEUTICS, INC. /DE/ (HRTX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.